logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 부산지방법원 2017.08.11 2014가단81814
손해배상(의)
Text

The defendant shall pay 5,00,000 won to the plaintiff and 5% per annum from November 1, 2014 to August 11, 2017, and the next day.

Reasons

Basic Facts

On August 30, 2014, the Plaintiff was diagnosed to be suspected of being Apduum cancer on the left upper line of the world at the Sychogymy conducted by the Busan Fine D Hospital located in the Geum-gu, Busan.

On September 5, 2014, the Plaintiff received a written request for medical treatment under the name of the injury or disease called “Apam Card” from the above hospital on September 11, 2014 and received medical treatment at the Busan Southern-gu E Hospital (hereinafter “Defendant Hospital”).

On September 11, 2014, the Defendant conducted a CT inspection to verify whether the AP cancer was transferred to the Plaintiff. As a result, the lower density of 4m is found on the left upper line, the lower density of 4m was found on the right upper line, the Defendant sent the same Rabdong-Gerosium to the right upper line, and the small number of trees was observed around the lower part.

On September 15, 2014, the Defendant registered the Plaintiff’s name of injury and disease with C73 (C73 in good faith) with the National Health Insurance Corporation. On September 23, 2014, the Plaintiff hospitalized in the Defendant Hospital and prepared a written consent for operation on September 23, 2014, and received A’s name of injury and disease from the left-hand side of the Defendant on September 24, 2014.

(hereinafter “instant surgery”). On September 25, 2014, the Defendant hospital: (a) requested a pathology test on the instant cutting-off organization to the H Institute located in Suwon-gu, Busan; and (b) on September 26, 2014, the Defendant hospital was diagnosed on September 26, 2014 that the instant cutting-off organization of the upper-tier vessel was not the sacrific surgery, and the saf system was not the saccine cancer.

On October 1, 2014, the Defendant issued a medical certificate, etc. for submission of an insurance company, which entered the final diagnosis name as E04 (other highly toxic Gap species).

[Ground of recognition] The plaintiff asserted the following facts: Gap 1 through 8, 12, 14, 16, 17, 18, Eul 1, 2, 4, and 6; the plaintiff asserted the purport of the whole oral argument; the plaintiff was diagnosed as being not the Gap ray cancer after an operation; the plaintiff was diagnosed as being not the Gap ray cancer after an operation.

(b).

arrow